This Article Full Text Full Text (PDF) All Versions of this Article: 40/6/2199    most recent STROKEAHA.108.540393v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Xue, M. Articles by Yong, V. W. Search for Related Content PubMed PubMed Citation Articles by Xue, M. Articles by Yong, V. W. Related Collections Animal models of human disease Neuroprotectors

(Stroke. 2009;40:2199.)
© 2009 American Heart Association, Inc.

Original Contributions

Relative Importance of Proteinase-Activated Receptor-1 Versus Matrix Metalloproteinases in Intracerebral Hemorrhage-Mediated Neurotoxicity in Mice

Mengzhou Xue, MD, PhD; Morley D. Hollenberg, DPhil, MD; Andrew Demchuk, MD V. Wee Yong, PhD

From the Hotchkiss Brain Institute and Department of Clinical Neurosciences (M.X., A.D., V.W.Y.) and the Department of Pharmacology and Therapeutics and the Department of Medicine (M.D.H.), University of Calgary, Calgary, Alberta, Canada.

Correspondence to V. Wee Yong, PhD, University of Calgary, 3330 Hospital Drive, Calgary, Alberta T2N 4N1, Canada. E-mail vyong{at}ucalgary.ca

Background and Purpose— To reduce bleeding and damage to central nervous system tissue in intracerebral hemorrhage, the coagulant effect of thrombin is essential. However, thrombin itself can kill neurons in intracerebral hemorrhage as can the matrix metalloproteinases (MMPs), which are also elevated in this condition, in part due to thrombin-mediated activation of MMPs. It is thus important to understand and block the neurotoxic effects of thrombin without inhibiting its therapeutic outcomes. In this study, we have investigated the relative roles of proteinase activated receptor-1, a thrombin receptor, and MMPs in brain injury induced by thrombin or blood.

Methods— Mice were subjected to stereotactic intracerebral injections of saline, thrombin, and autologous blood, with or without hirudin, a thrombin inhibitor, or GM6001, an MMP inhibitor. Twenty-four hours later, tissue sections were obtained to evaluate the area of brain damage and extent of dying neurons. Data from wild-type mice were compared with results obtained with proteinase activated receptor-1 null mice.

Results— In blood-induced damage to the brain parenchyma, both hirudin and GM6001 significantly reduced injury to a comparable extent (>40%) implicating both thrombin and MMPs in neurotoxicity. In proteinase activated receptor-1 null mice, blood-induced brain damage was reduced by 22.6% relative to wild-type animals; by comparison, the blood-induced brain damage was reduced by 48.3% using GM6001.

Conclusions— The neurotoxicity of blood in intracerebral hemorrhage involves both proteinase activated receptor-1 and MMP activation, with the latter appearing more prominent in causing death.

Key Words: intracerebral hemorrhage • MMPs • neurotoxicity • PAR₁ • thrombin